Pharmaceutical Companies Want a New, Expensive Drug

June 26 (Bloomberg) -- In today's "Single Best Chart," Bloomberg's Scarlet Fu displays the projected spending on research and development of specialty drugs by pharmaceutical companies. She speaks on "Bloomberg Surveillance."
Newell Rubbermaid's Currency Challenge `Massive': CEO
24:55 - Michael Polk, chief executive officer of Newell Rubbermaid Inc., talks about the company's first-quarter results and the impact of currency markets on Newell's earnings. Polk speaks with Alix Steel on Bloomberg Television's "Street Smart." (Source: Bloomberg)
  • Ashley Madison Tries to Hook Up With Investors
  • How Likely Is a Deal Between Microsoft and Salesforce?
  • Microsoft Said to Be Considering a Bid for Salesforce